Patrick M. O’Neil

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity

Thomas A. Wadden, Timothy S. Bailey, Liana K. Billings et al. · JAMA · 2021 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

Patrick M. O’Neil, Andreas L. Birkenfeld, Barbara McGowan et al. · The Lancet · 2018 · 804 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Vitamin D Supplementation and Prevention of Type 2 Diabetes

Anastassios G. Pittas, Bess Dawson‐Hughes, Patricia Sheehan et al. · New England Journal of Medicine · 2019 · 664 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial

Thomas A. Wadden, John P. Foreyt, Gary D. Foster et al. · Obesity · 2010 · 553 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study

Patrick M. O’Neil, Steven R. Smith, Neil J. Weissman et al. · Obesity · 2012 · 532 citations

Medicine, Pharmacology, Pharmacotherapy +17